Korean Drugmaker Cited for Quality, Testing Failures

Drug Industry Daily
A A
The FDA flagged South Korean drug manufacturer EEJE for quality and testing deficiencies observed during a July 30 to Aug. 2 inspection of its facility in Gyeongsangnam-do province.

To View This Article:

Login

Subscribe To Drug Industry Daily